MedTrace Logo

Colistin Pharmacokinetics in Critically Ill Patients During Extended Dialysis

NCT02556190 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2016-08-24

No results posted yet for this study

Summary

The emergence of multidrug-resistant bacteria has recently renewed interest in colistin. Data on dosing in critically ill patients undergoing extended dialysis are missing. The aim of this study is to determine the pharmacokinetics of colistin during extended dialysis in critically ill patients and to provide dosing guidelines for this drug.

Conditions

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Jan T Kielstein, Prof · Hannover Medical School, Dep. of Nephrology and Hypertension

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02556190 on ClinicalTrials.gov